Scott Henry
Stock Analyst at Alliance Global Partners
(1.68)
# 3,284
Out of 4,915 analysts
52
Total ratings
39.62%
Success rate
-2.78%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.02 | +194.12% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.48 | +153.38% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $4.33 | +38.57% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.27 | +205.81% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.72 | +284.08% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $7.35 | +15.65% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.24 | +222.58% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.85 | +710.81% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.47 | +2,464.65% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.60 | +13.64% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $10.75 | +20.93% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $32.57 | -26.31% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $21.33 | -27.33% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $81.25 | -28.62% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $58.34 | -38.29% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.30 | +746.15% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $5.59 | +7.33% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $2.43 | +236,525.51% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.01 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $1.93 | +262.69% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $37.68 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.58 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.04 | - | 1 | Nov 10, 2017 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.02
Upside: +194.12%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.48
Upside: +153.38%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $4.33
Upside: +38.57%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.27
Upside: +205.81%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.72
Upside: +284.08%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $7.35
Upside: +15.65%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.24
Upside: +222.58%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.85
Upside: +710.81%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.47
Upside: +2,464.65%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.60
Upside: +13.64%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $10.75
Upside: +20.93%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $32.57
Upside: -26.31%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $21.33
Upside: -27.33%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $81.25
Upside: -28.62%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $58.34
Upside: -38.29%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.30
Upside: +746.15%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $5.59
Upside: +7.33%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $2.43
Upside: +236,525.51%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $3.01
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $1.93
Upside: +262.69%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $37.68
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.58
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $4.04
Upside: -